Advanced Cancer Research: Driving Global Progress in Oncology Through Openness, Rigor and Innovation

Amid the accelerating evolution of global cancer research and clinical practice, oncology is undergoing a profound scientific transformation: shifting from a single discipline to multi-dimensional interdisciplinarity, moving from classical mechanism research to precision medicine and intelligent decision-making, and transitioning from laboratory innovation to the optimization of clinical protocols. Meanwhile, the academic publishing sector is at a critical juncture where Open Access and academic sharing are accelerating integration. Against this backdrop, Advanced Cancer Research has been launched — with a more open dissemination model and a more inclusive publishing vision, it undertakes the mission of advancing global oncology knowledge.

1. Journal Introduction

ISSN: 3106-0382 (Online)

Advanced Cancer Research is a fully open-access, online-only international academic journal. Its editorial board consists of international experts active in cancer research, clinical translation, and precision medicine, adhering to the editorial standards of rigor, innovation, and academic integrity in equal measure. The journal will be published quarterly, and all Article Processing Charges (APC) will be fully waived from 2025 to 2027. This initiative aims to promote knowledge sharing and ensure that high-quality scientific achievements benefit a broader global readership.

By nature, oncology is an interdisciplinary field spanning biology, clinical medicine, engineering, and data science. Advanced Cancer Research warmly welcomes submissions of original research that offer profound mechanistic insights, innovative methodologies, or a systemic understanding of cancer. Our goal is to benefit cancer patients worldwide by accelerating the translation of scientific discoveries into clinical applications. The journal covers a wide range of research topics, including but not limited to:

Cancer molecular mechanisms and signal transduction

Precision medicine and targeted therapy

Tumor microenvironment and metastasis

Immunotherapy and synthetic biology

Cancer genetics and epigenetics

Applications of emerging technologies in cancer research (e.g., multi-omics, liquid biopsy, organoids, etc.)

2. Founding Editor-in-Chief

Zigang Dong

Henan Medical College, Zhengzhou University & China–US (Henan) Hormel Cancer Institute, China

As the Vice President of Academic Affairs of Zhengzhou University and Dean of Henan Medical College, Professor Dong is a globally recognized authority in the field of cancer pathogenesis and cancer chemoprevention. He has long been engaged in research on tumorigenesis mechanisms and chemoprevention, having published more than 560 papers in internationally high-impact journals such as Nature, Nature Cell Biology, Nature Reviews Cancer, and Science Signaling, with a total citation count exceeding 40,000. He holds significant international academic influence in the field of tumor signal transduction and intervention strategies.

Professor Dong serves on the editorial boards of various authoritative journals including Cancer Research, and co-founded npj Precision Oncology in collaboration with the Nature Publishing Group. He has been honored with numerous international awards such as the McKnight Presidential Professor, Gallo Award, NIH Merit Award, and the Outstanding Contribution Award from the AACR Asia Committee. In 2021, he was listed in the global "Top 100,000 Scientists" ranking, ranking 3rd in the field of clinical medicine in mainland China, and was named a National Distinguished Leading Talent. In 2023, he was elected as a Foreign Member of the Russian Academy of Engineering, and in 2024, he was elected as a Member of the European Academy of Sciences.

3. Submission Types

We accept submissions of various article types, including Article, Letter, Review, Survey, Commentary, Perspective, etc., to fully showcase the diversity and depth of the cancer research field.

4. Contact Information

Journal Website:

https://www.elspub.com/journals/advanced-cancer-research/home/

Submission Link:

https://jms.elspub.com/login

Contact Email:

acr@elspub.com